Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 27-02 / BIG 1-02 

A randomized clinical trial of adjuvant chemotherapy for radically resected loco-regional relapse of breast cancer

Chemotherapy vs. observation

DESIGN

Design 27-02

Study Chairs
Prof. Stefan Aebi - Bern, Switzerland
Dr. Irene Wapnir - Stanford, USA

Statistician
Shari Gelber

Trial Coordinators
Karolyn Scott, Tara Scolese
IBCSG Data Management Center/FSTRF 4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 836 6097
Email: ibcsg27@fstrf.org

Date of Activation
July 31, 2002

Targeted Accrual
977 patients


Other Pathology


News

27.08.2010:
Activation of IBCSG Trial 38-10/BIG 3-07/TROG 07.01

19.08.2010:
A few impressions from our audits

09.08.2010:
Latest SOLE flash

All News

 
  Print